FATE Past Earnings image   This FATE past earnings page last updated 3/11/2024
FATE Past Earnings
PeriodPast Earnings DateGAAP
Q4 20232/26/2024-0.450
Q3 202311/8/2023-0.460
Q2 20238/8/2023-0.540
Q1 20235/3/2023-0.190
Q4 20222/28/2023-0.580
Q3 202211/3/2022-0.860
Q2 20228/3/2022-0.790
Q1 20225/4/2022-0.680
Q4 20212/28/2022-0.720
Q3 202111/4/2021-0.450
Q2 20218/4/2021-0.580
Q1 20215/5/2021-0.480
Q4 20202/24/2021-0.610
Q3 202011/5/2020-0.680
Q2 20208/5/2020-0.350
Q1 20205/11/2020-0.440
Q4 20193/2/2020-0.370
Q3 201911/5/2019-0.400
Q2 20198/6/2019-0.360
Q1 20195/7/2019-0.300
Q4 20183/5/2019-0.25
Q3 201811/1/2018-0.31
Q2 20188/6/2018-0.37
Q1 20185/10/2018-0.27
Q4 20173/5/2018-0.29
Q3 201711/1/2017-0.26
Q2 20178/14/2017-0.23
Q1 20175/15/2017-0.24
Q4 20163/16/2017-0.21
Q3 201611/7/2016-0.27
Q2 20168/8/2016-0.29
Q1 20165/9/2016-0.29
Q4 20153/3/2016-0.26
Q3 201511/3/2015-0.24
Q2 20158/5/2015-0.33
Q1 20155/7/2015-0.38
Q4 20143/12/2015-0.3
Q3 201411/11/2014-0.32
Q2 20148/12/2014-0.3
Q1 20145/13/2014-0.34
Q4 20133/17/2014-0.29
Q3 201311/13/2013-4.81
FATE Past Revenue
PeriodPast Earnings DateGAAP
Q4 20232/26/20240.00B
Q3 202311/8/20230.00B
Q2 20238/8/20230.00B
Q1 20235/3/20230.06B
Q4 20222/28/20230.04B
Q3 202211/3/20220.01B
Q2 20228/3/20220.02B
Q1 20225/4/20220.02B
Q4 20212/28/20220.02B
Q3 202111/4/20210.01B
Q2 20218/4/20210.01B
Q1 20215/5/20210.01B
Q4 20202/24/20210.02B
Q3 202011/5/20200.01B
Q2 20208/5/20200.01B
Q1 20205/11/20200.00B
Q4 20193/2/20200.00B
Q3 201911/5/20190.00B
Q2 20198/6/20190.00B
Q1 20195/7/20190.00B
Q4 20183/5/20191.66M
Q3 201811/1/20181.03M
Q2 20188/6/20181.03M
Q1 20185/10/20181.03M
Q4 20173/5/20181.03M
Q3 201711/1/20171.03M
Q2 20178/14/20171.03M
Q1 20175/15/20171.03M
Q4 20163/16/20171.03M
Q3 201611/7/20161.03M
Q2 20168/8/20161.03M
Q1 20165/9/20161.32M
Q4 20153/3/20161.08M
Q3 201511/3/20151.03M
Q2 20158/5/2015329000
Q1 20155/7/2015NA
Q4 20143/12/2015NA
Q3 201411/11/2014NA
Q2 20148/12/2014NA
Q1 20145/13/2014NA
Q4 20133/17/2014NA
Q3 201311/13/2013209000
Quotes delayed 20 minutes

Email EnvelopeFree FATE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Fate Therapeutics (FATE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

FBIO Past Earnings
FBRX Past Earnings
FDMT Past Earnings
FEMY Past Earnings
FGEN Past Earnings
FHTX Past Earnings
FIXX Past Earnings
FLDM Past Earnings
FLGT Past Earnings
FLXN Past Earnings

FATE Past Earnings Q&A

What was the best and worst FATE past earnings results?
For Fate Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest FATE past earnings result in our data set was -0.190/share posted in Q1 2023, while the lowest was in Q3 2013 when FATE posted -4.81/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2023 when FATE reported 0.06B in revenue, while the quarter with the lowest revenue in our data set was Q1 2015 at NA of revenue.

  Suggested answer: There are 42 FATE past earnings results in our data set.

On this page we presented the FATE past earnings date information for Fate Therapeutics. Reviewing that FATE Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2023, when FATE posted gaap of -0.190/share. Meanwhile the lowest FATE past earnings result was in Q3 2013, when FATE posted gaap of -4.81/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2023 when FATE reported 0.06B in revenue, while the smallest revenue quarter was Q1 2015 when FATE reported NA in revenue.

Any self directed investor doing their due diligence on FATE or any other given stock can benefit from researching all of the Fate Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Fate Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for FATE. Thanks for visiting, and the next time you need to research FATE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Boston Scientific market cap history, ETFs Holding PBI, NQE Historical Stock Prices.


FATE Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.